Stereotaxis (NYSEAMERICAN:STXS - Get Free Report) is projected to release its Q2 2025 earnings data after the market closes on Thursday, August 7th. Analysts expect Stereotaxis to post earnings of ($0.07) per share and revenue of $7.75 million for the quarter.
Stereotaxis Stock Performance
Shares of STXS stock traded down $0.13 during mid-day trading on Thursday, reaching $2.27. 450,594 shares of the company were exchanged, compared to its average volume of 630,297. Stereotaxis has a fifty-two week low of $1.54 and a fifty-two week high of $2.72. The company has a market capitalization of $195.22 million, a P/E ratio of -7.32 and a beta of 1.44. The business's 50 day simple moving average is $2.23 and its 200 day simple moving average is $2.13.
Stereotaxis Company Profile
(
Get Free Report)
Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.
Further Reading

Before you consider Stereotaxis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stereotaxis wasn't on the list.
While Stereotaxis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.